ScoreWhy is Indrayani Biotech Ltd ?
1
Weak Long Term Fundamental Strength with a -253.18% CAGR growth in Operating Profits over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 7.34 times
- The company has been able to generate a Return on Capital Employed (avg) of 7.90% signifying low profitability per unit of total capital (equity and debt)
2
The company has declared Negative results for the last 5 consecutive quarters
- PBT LESS OI(Q) At Rs -0.85 cr has Fallen at -194.44%
- PAT(Q) At Rs 0.16 cr has Fallen at -81.2%
- ROCE(HY) Lowest at -2.00%
3
Risky - Negative Operating Profits
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -61.40%, its profits have fallen by -166.3%
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -61.40% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Other Agricultural Products)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Indrayani Biotec for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Indrayani Biotec
-24.11%
-1.22
50.34%
Sensex
-11.8%
0.43
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
35.56%
EBIT Growth (5y)
21.71%
EBIT to Interest (avg)
1.56
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.70
Sales to Capital Employed (avg)
0.97
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
24.82%
Institutional Holding
3.13%
ROCE (avg)
7.73%
ROE (avg)
10.97%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
35
Industry P/E
34
Price to Book Value
0.98
EV to EBIT
44.61
EV to EBITDA
21.91
EV to Capital Employed
0.99
EV to Sales
1.33
PEG Ratio
0.30
Dividend Yield
NA
ROCE (Latest)
1.34%
ROE (Latest)
2.28%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
PAT(Latest six months)
Higher at Rs 1.52 cr
NET SALES(Q)
At Rs 37.71 cr has Grown at 29.59%
-1What is not working for the Company
NON-OPERATING INCOME(Q)
is 269.49 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Indrayani Biotec
Profit After Tax (PAT) - Latest six months
At Rs 1.52 cr has Grown at 118.16%
Year on Year (YoY)MOJO Watch
PAT trend is very positive
PAT (Rs Cr)
Profit After Tax (PAT) - Latest six months
Higher at Rs 1.52 cr
than preceding 12 month period ended Jun 2026 of Rs -7.85 crMOJO Watch
In the half year the company has already crossed PAT of the previous twelve months
PAT (Rs Cr)
Net Sales - Quarterly
At Rs 37.71 cr has Grown at 29.59%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Indrayani Biotec
Non Operating Income - Quarterly
is 269.49 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
